News

3. 3R-Symposium – Animal-free Methods in Pharmaceutical Research

Am 18. Oktober 2024 findet das dritte 3R-Symposium an der Universität des Saarlandes statt. Thema sind diesmal „tierfreie Methoden in der pharmazeutischen Forschung“.

Datum: 18. Oktober 2024
Uhrzeit: 9 bis 16 Uhr
Ort: Universität des Saarlandes, Campus Saarbrücken, Gebäude A3 3, Aula, 66123 Saarbrücken

https://www.3r-plattform-saar.de/3r-symposium/

24. September 2024

Mariana Guedes wins two awards at the 2024 European Congress on Alternatives to Animal Testing.

Our PhD student received a Young Scientist Travel award (250€) by the EUSAAT and the 3Rs student grant (1000€) by the European Partnership for Alternative Approaches to Animal Testing to participate in the 2024 EUSAAT congress in Linz, Austria.
She was selected to give an oral presentation about her work entitled "Establishing a lentiviral reporter platform for screening 3D human lung organoids: a proof-of-concept approach.".

The department extends its warmest congratulations.

18. July 2024

Congratulation to Thea Katharina Funke

We are delighted to announce that Thea Katharina Funke has successfully defended her MD-PhD thesis.

We extend our warmest congratulations and best wishes for her continued success in her future career.

11. July 2024

Congratulation to Hakon Heinze

We are pleased to announce that Hakon Klaus Heiko Heinze has successfully defended his MD-PhD thesis titled.

We extend our heartfelt congratulations and best wishes for his future endeavors.

June 2024

Prof Yildiz was recognised as a "Fachpharmakologe DGPT" in June 2024 and is looking forward to the corresponding further training of young scientists.

May 30-June 1st 2024

Flying off to the 2024 Summer Immersion on Innovative Approaches in Science

Our PhD candidate, Mariana Guedes, was awarded a 1500$ travel grant from the Physicians Committee for Responsible Medicine to attend the 2024 Summer Immersion on Innovative Approaches in Science in Washington DC.

Designed to educate the next generation of scientists committed to advancing science ethically using nonanimal methods for research and testing, this 3-day program provided an overview of in vitro, in silico, and in chemico approaches

and their many applications in basic, translational, and regulatory science to replace animals. Mariana presented her latest work on apical-out lung organoids as a poster entitled "Establishing a lentiviral reporter platform for screening 3D human lung organoids: a proof-of-concept approach.".

27. May 2024

Neue Professorin für Molekulare Pharmakologie an der Universität des Saarlandes ab 1. Juni 2024

12.-16. May 2024

Attending the Proteolysis at the membrane – from signaling to disease conference

We are pleased to announce that Daniela Yildiz, Ahmad Aljohmani and Federico Guillermo Gharzia participated in the Proteolysis at the membrane – from signaling to disease conference held in Kloster Seeon, Munich from 12th to 16th of May. This conference brought together experts and scholars from around the world to discuss and share the latest advancements in ectodomain shedding (ADAM, BACE, MMP proteases), intramembrane proteolysis (gamma-secretase, rhomboids, SPPL-proteases, S1P/S2P-proteases, signal-peptidase), protease “modulators” (such as tetraspanins and iRhoms) and inhibitors, substrate biology, proteolytic quality control as well as on therapeutic approaches.

Our participation included Flash talk and two posters with a tittle of “ADAM Proteases: A Pivotal Determinant in the Pathogenesis of Infectious Diseases” For Ahmad and “Ca2+-threshold dependency and spatial determination of ADAM10’s activation” for Federico.

We look forward to applying the insights gained from this conference to our ongoing work and contributing further to the field.

April 2024

Congratulations to Ahmad Aljohmani

We are thrilled to announce that Ahmad Aljohmani has successfully defended his PhD thesis, earning a summa cum laude distinction. This is a remarkable achievement and a testament to his hard work, dedication, and scholarly excellence.

March 2024

Poster prize at the 9th German Pharma-Tox summit

Poster prize at the 9th German Pharma-Tox summit

Ahmad Aljohmani won the best poster prize at the 9th German Pharm-Tox Summit in Munich for his work on ADAM proteases as a therapeutic and prognostic target. The poster was titled “The emerging roles of the proteolytic and non-proteolytic activity of ADAM proteases as a therapeutic and prognostic target in infectious diseases”.